MBody AI Ltd. (MBAI) vs Revelation Biosciences, Inc. (REVB)
A side-by-side comparison of MBody AI Ltd. and Revelation Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
MBAI
MBody AI Ltd.
$3.20HealthcareDelayed quote: Oct 6, 2026, 3:54 PM EDT
REVB
Revelation Biosciences, Inc.
$0.75HealthcareDelayed quote: Oct 6, 2026, 3:49 PM EDT
Total return — MBAI vs REVB
growth of $100 · dividends reinvested · last 1yMBAI -67.4% (-67.4%/yr)REVB -84.5% (-84.5%/yr)MBAI compounded faster over this window
MBAI REVB
MBAI vs REVB: by the numbers
- •MBAI is the larger company ($3M vs $3M market cap).
Metrics side by side
Valuation
| Metric | MBAI | REVB |
|---|---|---|
| P/B ratio | 0.93 | 0.29 |
Profitability
| Metric | MBAI | REVB |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | 120.45% | -106.79% |
| ROIC | -69.04% | -104.28% |
Growth (annualized)
| Metric | MBAI | REVB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -93.52% |
Go deeper
Dig into the metrics
MBody AI ROERevelation Biosciences ROEMBody AI operating marginRevelation Biosciences operating marginMBody AI revenue growthRevelation Biosciences revenue growthMBody AI free cash flowRevelation Biosciences free cash flow
MBody AI & Revelation Biosciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.